{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:06:29Z","timestamp":1782295589638,"version":"3.54.5"},"reference-count":84,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0161kolstv\u00ed ml\u00e1de\u017ee a t\u011blov\u00fdchovy \u010cesk\u00e9 republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo zdravotnictv\u00ed \u010cesk\u00e9 republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.amjms.2021.10.012","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T11:26:22Z","timestamp":1636197982000},"page":"465-475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["COVID-19 associated coagulopathy: Mechanisms and host-directed treatment"],"prefix":"10.1016","volume":"363","author":[{"given":"Ji\u0159\u00ed","family":"Pl\u00e1\u0161ek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gumulec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"M\u00e1ca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"\u0160karda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Proch\u00e1zka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Gr\u00e9zl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"V\u00e1clav\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2021.10.012_bib0001","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.amjms.2021.10.012_bib0002","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameterers are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.amjms.2021.10.012_bib0003","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1148\/radiol.2020201561","article-title":"Acute Pulmonary embolism in patients with COVID-19 at CT angiography and relationship to d-dimer levels","volume":"296","author":"L\u00e9onard-Lorant","year":"2020","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.amjms.2021.10.012_bib0004","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.120.047430","article-title":"Pulmonary embolism in patients with COVID-19:awareness of an increased prevalence","volume":"142","author":"Poissy","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.amjms.2021.10.012_bib0005","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol"},{"issue":"2","key":"10.1016\/j.amjms.2021.10.012_bib0006","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.amjms.2021.10.012_bib0007","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1473-3099(20)30237-1","article-title":"Understanding COVID-19: what does viral RNA load really mean?","volume":"20","author":"Joynt","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"20","key":"10.1016\/j.amjms.2021.10.012_bib0008","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzymy 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.amjms.2021.10.012_bib0009","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","article-title":"ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers in the endothelial surface under flowing conditions","volume":"100","author":"Dong","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.amjms.2021.10.012_bib0010","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2007-12-130740","article-title":"Basal secretion of von Willebrand factor from human endothelial cells","volume":"112","author":"Giblin","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.amjms.2021.10.012_bib0011","doi-asserted-by":"crossref","unstructured":"Lopes da Silva M, Cutler D. von Willebrand factor multimerization and the polarity of secretory pathways in endothelial cells. Blood. 2016;128(2):277\u2013285.","DOI":"10.1182\/blood-2015-10-677054"},{"issue":"5","key":"10.1016\/j.amjms.2021.10.012_bib0012","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1203\/00006450-200105000-00008","article-title":"Willebrand factor and von Willebrand factor-cleaving metalloprotease aktivity in Escherichia coli 0157: H7-associated hemolytic uremic syndrome","volume":"49","author":"Von","year":"2001","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1016\/j.amjms.2021.10.012_bib0013","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI112129","article-title":"Substructure of human von Willebrand factor","volume":"76","author":"Fowler","year":"1985","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.amjms.2021.10.012_bib0014","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1182\/blood.V88.8.2939.bloodjournal8882939","article-title":"Shear dependent changes in the three-dimensional structure of human von Willebrand factor","volume":"88","author":"Siedlecki","year":"1996","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.amjms.2021.10.012_bib0015","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1182\/blood-2011-02-306597","article-title":"Unravelling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor","volume":"118","author":"Crawley","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.amjms.2021.10.012_bib0016","first-page":"63","article-title":"A short history of platelet glycoprotein Ib complex","volume":"98","author":"Cemetson","year":"2007","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.amjms.2021.10.012_bib0017","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.cellsig.2004.05.008","article-title":"Signaling through the platelet glykoprotein Ib-V-IX","volume":"16","author":"Canobio","year":"2004","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.amjms.2021.10.012_bib0018","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jacc.2005.08.055","article-title":"Dependence of platelet thrombus stability on sustained glycoprotein IIb\/IIIa activation through adenosine 5\u2018-diphospate receptor stimulation and cyclic calcium signaling","volume":"47","author":"Goto","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.amjms.2021.10.012_bib0019","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1111\/jth.15107","article-title":"COVID-19 patients exhibit reduced procoagulant platelet responses","volume":"18","author":"Denorme","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.amjms.2021.10.012_bib0020","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.amjms.2021.10.012_bib0021","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/M20-2566","article-title":"Pulmonary arterial thrombo- sis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series","volume":"173","author":"Lax","year":"2020","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.amjms.2021.10.012_bib0022","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.amjms.2021.10.012_bib0023","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/hae.14089","article-title":"Registry of patients with congenital bleeding disorders and COVID-19 in Madrid","volume":"26","author":"\u00c1lvarez-Roman","year":"2020","journal-title":"Haemophilia"},{"issue":"7","key":"10.1016\/j.amjms.2021.10.012_bib0024","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1055\/s-0040-1713435","article-title":"Patients with congenital bleeding disorders appear to be less severely affected by SRS-CoV-2: is inherited hypocoagulability overcoming acquired hypercoagulability of coronavirus disease 2019 (COVID-19)?","volume":"46","author":"Dorgalaleh","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"6201","key":"10.1016\/j.amjms.2021.10.012_bib0025","doi-asserted-by":"crossref","DOI":"10.1126\/science.1256070","article-title":"Intracellular sensing of complement C3 activates cell autonomous immunity","volume":"345","author":"Tam","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.amjms.2021.10.012_bib0026","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ni.2548","article-title":"Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21","volume":"14","author":"McEwan","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.amjms.2021.10.012_bib0027","first-page":"1","article-title":"The complement system: an overview","volume":"150","author":"Morgan","year":"2000","journal-title":"Methods Mol Biol"},{"issue":"11","key":"10.1016\/j.amjms.2021.10.012_bib0028","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1111\/jth.15050","article-title":"Is the COVID-19 thrombotic catastrophe complement-connected?","volume":"18","author":"Conway","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.amjms.2021.10.012_bib0029","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3949\/ccjm.87a.ccc008","article-title":"Cytokine storm and the prospects for immunotherapy with COVID-19","volume":"87","author":"Calabrese","year":"2020","journal-title":"Cleve Clin J Med"},{"issue":"8","key":"10.1016\/j.amjms.2021.10.012_bib0030","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood-2009-01-199117","article-title":"Role of tissue factor in a mouse model of thrombotic mi- croangiopathy induced by antiphospholipid (aPL) antibodies","volume":"114","author":"Seshan","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.amjms.2021.10.012_bib0031","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.20041497","article-title":"Platelet activation leads to activation and propagation of the com- plement system","volume":"201","author":"Del Conde","year":"2005","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.amjms.2021.10.012_bib0032","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.amjms.2021.10.012_bib0033","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1038\/s41598-021-82810-3","article-title":"Complement C3 identified as a unique risk factor for disease severity among young COVID-19 patients in Wuhan, China","volume":"11","author":"Cheng","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjms.2021.10.012_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107070","article-title":"Decreased complement C3 level are associated with poor prognosis in patients with COVID-19: a retrospective cohort study","volume":"89","author":"Fang","year":"2020","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.amjms.2021.10.012_bib0035","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.4081\/hr.2017.7053","article-title":"Atypical hemolytic uremic syn- drome: a brief review","volume":"9","author":"Zhang","year":"2017","journal-title":"Hematol Rep"},{"key":"10.1016\/j.amjms.2021.10.012_bib0036","doi-asserted-by":"crossref","first-page":"17028","DOI":"10.1038\/nrdp.2017.28","article-title":"Paroxysmal nocturnal haemoglobinuria","volume":"3","author":"Hill","year":"2017","journal-title":"Nat Rev Dis Prim"},{"issue":"25","key":"10.1016\/j.amjms.2021.10.012_bib0037","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","article-title":"Thrombosis in paroxysmal nocturnal he- moglobinuria","volume":"121","author":"Hill","year":"2013","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.amjms.2021.10.012_bib0038","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.thromres.2014.03.010","article-title":"The procoagulant envelope virus surface: contribution to enhanced infection","volume":"133","author":"Pryzdial","year":"2014","journal-title":"Thromb Res"},{"issue":"25","key":"10.1016\/j.amjms.2021.10.012_bib0039","doi-asserted-by":"crossref","first-page":"13510","DOI":"10.1073\/pnas.94.25.13510","article-title":"Coagulation initiated on herpesviruses","volume":"94","author":"Sutherland","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.amjms.2021.10.012_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104362","article-title":"Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past","volume":"127","author":"Giannis","year":"2020","journal-title":"J Clin Virol"},{"issue":"5","key":"10.1016\/j.amjms.2021.10.012_bib0041","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/infdis\/jiv499","article-title":"Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4","volume":"213","author":"Li","year":"2016","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.amjms.2021.10.012_bib0042","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.amjms.2021.10.012_bib0043","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.amjms.2021.10.012_bib0044","first-page":"711","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"58","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2021.10.012_bib0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.amjms.2021.10.012_bib0046","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1111\/jth.15032","article-title":"Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infection","volume":"18","author":"Lachant","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.amjms.2021.10.012_bib0047","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/jth.14578","article-title":"Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation","volume":"17","author":"Iba","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.amjms.2021.10.012_bib0048","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19","volume":"76","author":"Paranjpe","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2021.10.012_bib0049","first-page":"790","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with COVID-19","volume":"85","author":"Lawler","year":"2021","journal-title":"N Eng J Med"},{"key":"10.1016\/j.amjms.2021.10.012_bib0050","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with covid-19","volume":"385","author":"Goligher","year":"2021","journal-title":"N Engl J Med"},{"issue":"397","key":"10.1016\/j.amjms.2021.10.012_bib0051","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated d-dimer concentration (ACTION): an open lable, multicentre, randomized, controlled trial","volume":"12","author":"Lopes","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.amjms.2021.10.012_bib0052","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jacc.2020.08.041","article-title":"Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19","volume":"76","author":"Nadkarni","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2021.10.012_bib0053","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11239-020-02162-z","article-title":"The association between treatment with heparin and survival in patients with COVID-19","volume":"50","author":"Ayerbe","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.amjms.2021.10.012_bib0054","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.thromres.2020.09.026","article-title":"Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID)","volume":"196","author":"Lemos","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjms.2021.10.012_bib0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijcard.2020.09.064","article-title":"Antithrombotic therapy in patients with COVID-19? Rationale and evidence","volume":"324","author":"Godino","year":"2021","journal-title":"Int J Cardiol"},{"issue":"60","key":"10.1016\/j.amjms.2021.10.012_bib0056","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cyto.2012.06.008","article-title":"Unfractionated heparin inhibits lipopolysaccharide- induced inflammatory response through blocking p38 MAPK and NF-\u03baB activation on endothelial cell","author":"Li","year":"2012","journal-title":"Cytokine"},{"issue":"108","key":"10.1016\/j.amjms.2021.10.012_bib0057","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1172\/JCI200113530","article-title":"Molecular diversity of heparan sulfate","author":"Esko","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjms.2021.10.012_bib0058","doi-asserted-by":"crossref","unstructured":"Mycroft-West CJ, Su D, Elli S, et al. The 2019 coronavirus (SARSCoV-2) surface protein (Spike) S1 receptor binding domain undergoes conformational change upon heparin binding. BioRxiv Preprint April 29, 2020. doi: 10.1101\/2020.02.29.971093.","DOI":"10.1101\/2020.02.29.971093"},{"issue":"359","key":"10.1016\/j.amjms.2021.10.012_bib0059","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbrc.2007.05.092","article-title":"Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity","author":"Du","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.amjms.2021.10.012_bib0060","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1111\/bjh.16927","article-title":"Anticoagulation with argatroban in patients with acute antithtombin deficiency in severe COVID-19","volume":"190","author":"Arachchillage","year":"2020","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.amjms.2021.10.012_bib0061","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40560-020-00491-y","article-title":"Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC","volume":"18","author":"Asakura","year":"2020","journal-title":"J Intensive Care"},{"key":"10.1016\/j.amjms.2021.10.012_bib0062","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1053\/j.jvca.2019.05.035","article-title":"Streptokinase versus unfractionated heparin nebulization in patients with severe acute respiratory distress syndrome (ARDS): a randomized controlled trial with observational controls","volume":"34","author":"Abdelaal Ahmed Mahmoud","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"7","key":"10.1016\/j.amjms.2021.10.012_bib0063","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201406-1031OC","article-title":"Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis","volume":"191","author":"Le","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.amjms.2021.10.012_bib0064","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1462-5822.2007.00902.x","article-title":"Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting aktivity","volume":"9","author":"Mazur","year":"2007","journal-title":"Cell Microbiol"},{"issue":"3","key":"10.1016\/j.amjms.2021.10.012_bib0065","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/QAI.0b013e31828a292c","article-title":"Aspirin attenuates platelet activation and immune activation in HIV-1 infected subjects n Antiretroviral therapy: a pilot study","volume":"63","author":"O'Brien","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.amjms.2021.10.012_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tru.2020.100026","article-title":"Antiplatelet therapy in patients with COVID-19: a retrospective observational study","volume":"2","author":"Banik","year":"2021","journal-title":"Thromb Update"},{"key":"10.1016\/j.amjms.2021.10.012_bib0067","article-title":"Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis","volume":"29","author":"Malas","year":"2020","journal-title":"EclinicalMedicine"},{"issue":"3","key":"10.1016\/j.amjms.2021.10.012_bib0068","first-page":"112","article-title":"Mortality of COVID-19 patients with vascular thrombotic complications","volume":"156","author":"Gonazales-Fajardo","year":"2021","journal-title":"Med Clin"},{"key":"10.1016\/j.amjms.2021.10.012_bib0069","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjms.2021.10.012_bib0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.thromres.2020.04.028","article-title":"Thrombotic complications of patients admitted to intensive care with COVID-19 at teaching hospital in the United Kingdom","volume":"191","author":"Thomas","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjms.2021.10.012_bib0071","first-page":"1","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a mlticenter prospective cohort study","volume":"4","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.amjms.2021.10.012_bib0072","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/bjh.17522","article-title":"Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis","volume":"191","author":"Tholin","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjms.2021.10.012_bib0073","first-page":"10","article-title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","volume":"6","author":"Cui","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"22","key":"10.1016\/j.amjms.2021.10.012_bib0074","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAd0x1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2021.10.012_bib0075","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Gundabolu. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination","volume":"384","author":"Kallam","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2021.10.012_bib0076","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antiboides to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Eng J Med"},{"key":"10.1016\/j.amjms.2021.10.012_bib0077","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/jmv.26509","article-title":"Efficacy of tocilizumab I COVID-19: a systematic review and meta-analysis","volume":"93","author":"Aziz","year":"2021","journal-title":"J Med Virol"},{"issue":"24","key":"10.1016\/j.amjms.2021.10.012_bib0078","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1056\/NEJMoa2028836","article-title":"Efficacy of tocilizumab in patients hospitalized with COVID-19","volume":"383","author":"Stone","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjms.2021.10.012_bib0079","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.amjms.2021.10.012_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100590","article-title":"Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: a proof of concept study","volume":"28","author":"Annane","year":"2020","journal-title":"EclinicalMedicine"},{"key":"10.1016\/j.amjms.2021.10.012_bib0081","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2147\/DDDT.S134470","article-title":"Caplacizumab as an emerging treatment option for aquired thrombotic thrombocytopenic purpura","volume":"13","author":"Elverdi","year":"2019","journal-title":"Drugs Des Dev Ther"},{"issue":"7","key":"10.1016\/j.amjms.2021.10.012_bib0082","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jama.2021.0202","article-title":"Effect of bamlanivimab as monotherapy or in ombination with etesevimab on viral lod in patients with mild to moderate COVID-19:a randomized clinical trial","volume":"325","author":"Gottlieb","year":"2021","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.amjms.2021.10.012_bib0083","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.thromres.2021.02.012","article-title":"Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19","volume":"201","author":"Turecek","year":"2021","journal-title":"Thromb Res"},{"issue":"395","key":"10.1016\/j.amjms.2021.10.012_bib0084","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S0140-6736(20)30305-6","article-title":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option","author":"Zumla","year":"2020","journal-title":"Lancet"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921004031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921004031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:40:29Z","timestamp":1757702429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962921004031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0002962921004031"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2021.10.012","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 associated coagulopathy: Mechanisms and host-directed treatment","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2021.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}